He is a medical oncologist and the co-founder of several personalized medicine companies. Dr. Agus is an international leader in new technologies and approaches for personalized healthcare, serving in leadership roles at the World Economic Forum, among other prestigious organizations.
Dr. Durham's clinical work is focused on management of complex patients with melanoma in the Multidisciplinary Melanoma Program in addition to Mohs surgery and associated reconstruction. Her clinical research is focused on skin cancer epidemiology, therapy, education, and biology. She has used her clinical environment as a research base that facilitates advancement of knowledge in her field, particularly in melanoma. She serves as Faculty Director of established biobanks in both non-melanoma and melanoma skin cancer.
During her medical school, residency, fellowship, and her junior faculty years, Dr. Tsikitis won numerous awards in research, patient care, and teaching, including Outstanding Intern and Outstanding Resident awards, as well as Outstanding Role Model in Surgery. Institutionally, she is the Cancer Liaison Physician for the Commission on Cancer, and is sought after, both institutionally and locally to lecture on colon and rectal cancer, Inflammatory Bowel Disease (IBD).
She received her Doctor of Medicine Degree from George Washington University in 2002. She then completed 3 years of a General Surgical Categorical residency at Brown University/Rhode Island Hospital. From 2005 to 2006, she completed a Cutaneous Oncology Fellowship at the University of California, San Francisco. She then completed a Dermatology residency and an additional year of dermatologic research graduating in 2010 from the University of California, Irvine. After their Dermatology residency, she completed a Mohs Micrographic Surgery Fellowship at St. John’s Institute of Dermatology, London, the UK in 2011.
This section has yet to be updated by the user.